Bronchiectasis frequent exacerbations — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Consider long-term macrolide therapy after counselling and monitoring
Long-term macrolide therapy can reduce exacerbations in selected bronchiectasis patients after optimisation, ECG assessment and exclusion of NTM infection. Long-term ciprofloxacin is not preferred because of resistance and toxicity. ICS monotherapy is not bronchiectasis disease-modifying unless there is coexisting asthma or eosinophilic disease.
Reference: BTS Guideline for Bronchiectasis in Adults 2019; BTS long-term macrolide guidance